Opportunity ID: 297293

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-17-479
Funding Opportunity Title: NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 11, 2017
Last Updated Date:
Original Closing Date for Applications: Jan 05, 2018
Current Closing Date for Applications: Jan 05, 2018
Archive Date: Feb 10, 2018
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support clinical trials for projects that were previously funded by NIH SBIR and STTR Phase II awards. The projects must focus on products related to the mission and goals of the National Institute of Neurological Disorders and Stroke (NINDS) and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Since conducting the clinical trials needed for commercialization may be capital-intensive, the FOA aims to facilitate the transition of SBIR Phase II projects to the commercialization stage by promoting partnerships between NIHs SBIR/STTR awardees and third-party investors and/or strategic partners. Consistent with the goals of this funding initiative and as required by the SF424 instructions for all SBIR Phase II applications, applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will equal or exceed the NINDS funds being requested throughout the SBIR Phase IIB project period.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-17-479.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-D Use for due dates on or after May 25, 2016 PKG00234688 Dec 05, 2017 Jan 05, 2018 View

Package 1

Mandatory forms

297293 RR_SF424_2_0-2.0.pdf

297293 PHS398_CoverPageSupplement_3_0-3.0.pdf

297293 RR_OtherProjectInfo_1_3-1.3.pdf

297293 PerformanceSite_2_0-2.0.pdf

297293 RR_KeyPersonExpanded_2_0-2.0.pdf

297293 RR_Budget_1_3-1.3.pdf

297293 PHS398_ResearchPlan_3_0-3.0.pdf

297293 SBIR_STTR_Information_1_1-1.1.pdf

Optional forms

297293 RR_SubawardBudget30_1_3-1.3.pdf

297293 PHS_Inclusion_Enrollment_Report-1.0.pdf

297293 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T17:12:30-05:00

Share This Post, Choose Your Platform!

About the Author: